Chris Parker

基本信息

浏览量：501

职业迁徙

个人简介

Professor Parker led the clinical development of radium-223, a targeted alpha-emitter for the treatment of bone metastases. The ALSYMPCA trial demonstrated that radium-223 improves overall survival and quality of life in men with advanced prostate cancer and has a favourable safety profile.

He also led the Medical Research Council STAMPEDE RT/M1 comparison. The results showed that prostate radiotherapy improves overall survival in men with low burden metastatic disease.

研究兴趣

论文共 642 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

Silke Gillessen,Fabio Turco,Ian D. Davis,Jason A. Efstathiou,Karim Fizazi,Nicholas D. James,Neal Shore,Eric Small,Matthew Smith,Christopher J. Sweeney,Bertrand Tombal,Thomas Zilli,Neeraj Agarwal,Emmanuel S. Antonarakis,Ana Aparicio,Andrew J. Armstrong,Diogo Assed Bastos,Gerhardt Attard,Karol Axcrona,Mouna Ayadi,Himisha Beltran,Anders Bjartell,Pierre Blanchard,Maria T. Bourlon,Alberto Briganti,Muhammad Bulbul,Consuelo Buttigliero,Orazio Caffo,Daniel Castellano,Elena Castro,Heather H. Cheng,Kim N. Chi,Caroline S. Clarke,Noel Clarke,Johann S. De Bono,Maria De Santis,Ignacio Duran,Eleni Efstathiou,Onyeanunam N. Ekeke, Tamer I. H. El Nahas,Louise Emmett,Stefano Fanti,Omolara A. Fatiregun,Felix Y. Feng,Peter C. C. Fong,Valerie Fonteyne,Nicola Fossati,Daniel J. George,Martin E. Gleave,Gwenaelle Gravis,Susan Halabi,Daniel Heinrich,Ken Herrmann,Michael S. Hofman,Thomas A. Hope,Lisa G. Horvath,Maha H. A. Hussain,Barbara Alicja Jereczek-Fossa,Robert J. Jones,Anthony M. Joshua, Ravindren Kanesvaran,Daniel Keizman,Raja B. Khauli,Gero Kramer,Stacy Loeb,Brandon A. Mahal,Fernando C. Maluf,Joaquin Mateo,David Matheson, Mika P. Matikainen,Ray McDermott,Rana R. McKay,Niven Mehra,Axel S. Merseburger,Alicia K. Morgans,Michael J. Morris,Hind Mrabti,Deborah Mukherji,Declan G. Murphy,Vedang Murthy,Shingai B. A. Mutambirwa,Paul L. Nguyen,William K. Oh,Piet Ost,Joe M. O'Sullivan,Anwar R. Padhani,Chris Parker,Darren M. C. Poon,Colin C. Pritchard,Danny M. Rabah,Dana Rathkopf,Robert E. Reiter,Raphaele Renard-Penna,Charles J. Ryan,Fred Saad,Juan Pablo Sade,Shahneen Sandhu,Oliver A. Sartor,Edward Schaeffer,Howard I. Scher,Nima Sharifi,Iwona A. Skoneczna,Howard R. Soule,Daniel E. Spratt,Sandy Srinivas,Cora N. Sternberg,Hiroyoshi Suzuki,Mary-Ellen Taplin,Camilla Thellenberg-Karlsson,Derya Tilki,Levent N. Turkeri,Hiroji Uemura,Yuksel Urun,Claire L. Vale,Neha Vapiwala,Jochen Walz,Kosj Yamoah,Dingwei Ye,Evan Y. Yu,Almudena Zapatero,Aurelius Omlin

EUROPEAN UROLOGYno. 2 (2025): 157-216

引用1浏览0WOS引用

Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial

Priyanka Patel, Sabine Dreibe,Gerhardt Attard,Aidan Cole, Patricia Diez, John Frew, Jeane Guevara,Daniel Levine,Fiona McDonald, Vinod Mullassery,Julia Murray,Chris Parker, Nachi Palaniappan,Angela Pathmanathan,Alison Reid,Yae-Eun Suh,Isabel Syndikus, Angelie Tirona, Amina Tran,Nina Tunariu, Nicholas J van As,James Wylie, Alison C Tree

International journal of radiation oncology, biology, physics (2025)

引用0浏览0WOS引用

Generalizing Imaging Biomarker Repeatability Studies Using Bayesian Inference: Applications in Detecting Heterogeneous Treatment Response in Whole-Body Diffusion-Weighted MRI of Metastatic Prostate Cancer

Matthew D Blackledge, Konstantinos Zormpas-Petridis, Ricardo Donners,Antonio Candito, David J Collins,Johann de Bono,Chris Parker, Dow-Mu Koh,Nina Tunariu

arxiv（2025）

引用0浏览0引用

Chemical Probes for the Identification of the Molecular Targets of Honokiol

Henar Vazquez-Villa,Ainoa Rueda-Zubiaurre, Daniel Fernandez, Roman Foronda,Christopher G. Parker,Benjamin F. Cravatt,Mar Martin-Fontecha,Silvia Ortega-Gutierrez

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2025)

引用0浏览0WOS引用

Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer

Arun A Azad,Louise Kostos,Neeraj Agarwal,Gerhardt Attard,Ian D Davis,Tanya Dorff,Silke Gillessen,Chris Parker,Matthew R Smith,Christopher J Sweeney,Bertrand Tombal,Karim Fizazi

European urologyno. 4 (2025): 455-467

引用0浏览0WOS引用

HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy

Sian Cooper, Rosalyne L Westley, Katie Biscombe,Alex Dunlop, Adam Mitchell,Uwe Oelfke, Simeon Nill,Georgina Manning, Stephanie Burnett,Julia Murray,Anna Wilkins,Nina Tunariu, Derek Price, Aidan Adkins,Angela Pathmanathan, Greta Bucinskaite, Shaista Hafeez,Chris Parker, Ragu Ratnakumaran,Helena Verkooijen, Sophie Alexander, Trina Herbert,Emma Hall, Alison C Tree

International journal of radiation oncology, biology, physics (2025)

引用0浏览0WOS引用

Counterpoint: the Perplexing Prevalence of Hydrogel Spacer Devices: We Simply Don't Need Them

William A. Hall,Chris Parker

International Journal of Radiation OncologyBiologyPhysicsno. 1 (2024): 36-37

引用0浏览0WOS引用

Reply to “Letter to the Editor regarding “Timing of radiotherapy (RT) after radical prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]”, by C. C. Parker et al.”